Brief: Transcode Therapeutics Announces FDA Authorization To Proceed With First-In-Human Clinical Trial
29/12/2022 13:07
Dec 29 (Reuters) - Transcode Therapeutics Inc RNAZ.O :
* TRANSCODE THERAPEUTICS ANNOUNCES FDA AUTHORIZATION TO
PROCEED
WITH FIRST-IN-HUMAN CLINICAL TRIAL
Source text for Eikon: ID:nGNX4rrhR0
Further company coverage: RNAZ.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors